Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03898752
Other study ID # MiOxysis_Skive
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 1, 2018
Est. completion date November 1, 2020

Study information

Verified date March 2021
Source Regionshospitalet Viborg, Skive
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In this study we aim to investigate whether a 3-month life-style intervention would reduce oxidative stress (OS) in semen in men of infertile couples attending IVF-treatment. Men with a DFI above 15% (SCSA method) are recruited for intervention with a 3-month follow-up. It is hypothesized that men who also have a OS above 1.34 using a novel OS diagnostic method (MiOXSYS) respond better to antioxidant treatment with a change in OS and DFI. The primary outcome is the change in OS following the intervention. Secondary outcomes are morphological semen parameters and DNA fragmentation index.


Recruitment information / eligibility

Status Completed
Enrollment 31
Est. completion date November 1, 2020
Est. primary completion date May 1, 2020
Accepts healthy volunteers No
Gender Male
Age group 18 Years and older
Eligibility Inclusion Criteria: - DFI>15 - Attending IVF treatment for unknown or male factor infertility. Exclusion Criteria: - Genetic diseases - Azospermia

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Omega 3
Omega 3: 1g daily for 3 months CoQ10: 100 mg daily for 3 months Multivitamin: 1 normal multivitamin tablet daily for 3 months

Locations

Country Name City State
Denmark The Fertility Clinic Skive Skive Central Denmark Region

Sponsors (1)

Lead Sponsor Collaborator
Peter Humaidan

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary Oxidative stress Oxidative stress as measured with MiOxysis (Ayto Bioscience inc). 3 months
Secondary Semen quality Morphological semen parameters using WHO recommendation for semen analysis. 3 months
Secondary DNA fragmentation index DNA fragmentation index as measured by the method by SPZlab A/S (SCSA method) 3 months
See also
  Status Clinical Trial Phase
Recruiting NCT05506722 - Using of Testes Shocker in Improving the Spermatogenesis and Sperms Activity N/A
Recruiting NCT04795440 - Comparison of ICSI Outcomes in Cycles Using Testicular and Ejaculate Sperm From Couples With High SDF N/A
Recruiting NCT02063256 - 7 NUTS Study. Diet Modification and Male Fertility. Phase 2/Phase 3
Active, not recruiting NCT05134428 - Safety Evaluation of the ADAM System N/A
Not yet recruiting NCT06260007 - Efficacy and Safety Study of Products Based on Tribulus Terrestris, L. in Men With Oligospermia Phase 4
Terminated NCT00440180 - Aromatase Inhibitors in the Treatment of Male Infertility Phase 3
Completed NCT01409837 - The Effect and Safety of Lisinopril in Non-hypertensive Men With Infertility From Low Sperm Count Phase 2
Completed NCT01239186 - Identification and Characterization of the Methylation Abnormalities on Whole Genome Among Infertile Men N/A
Not yet recruiting NCT00479960 - A Preliminary Study on Effect of Omega-3 on Human Sperm Phase 0
Recruiting NCT06342856 - Evaluation of Treatment With Coenzyme Q10 and L-Carnitine on Semen Parameters in Infertile Men With Idiopathic Oligoasthenoteratospermia Early Phase 1
Recruiting NCT01856361 - Ramipril for the Treatment of Oligospermia N/A
Recruiting NCT05842239 - Hyperbaric Oxygen Therapy for Men Suffering From Infertility Due to Oligospermia. N/A
Not yet recruiting NCT01520584 - Supplement Intake in Infertile Men;the Effect on Sperm Parameters,Fertilization Rate and Embryo Quality N/A
Completed NCT01509482 - Insulin Resistance in Idiopathic Oligospermia and Azoospermia N/A
Completed NCT00548977 - Genetic Studies Spermatogenic Failure N/A
Completed NCT04349345 - Seminal Fluid's Changes Over 20 Years
Recruiting NCT05320536 - A Clinical Study of Gulingji Capsule in the Treatment of Idiopathic Oligospermia, Asthenia, and Teratozoospermia Phase 4
Recruiting NCT05158114 - Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Testicular Injury and Oligospermia Phase 1
Completed NCT02234206 - A Clinical Trial to Study the Safety and Efficacy of Chandrakanthi Choornam in Patients With Low Sperm Count Phase 2
Recruiting NCT06202469 - Creatine and Ubiquinol for Sperm Quality N/A